Developments Psyence reports major breakthrough in establishing pharmaceutical-grade ibogaine supply Psyence BioMedical (NASDAQ: BPM) has announced it has sourced a sustainable supply of high-potency iboga bark—through its strategic partner, closely held PsyLabs—a significant achievement as the company prepares for the... November 20, 2025